Cefadroxil Sinphar

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cefadroxil Sinphar

Property Description
Active ingredient Cefadroxil
Form Oral capsule, tablet, or suspension
Pharmacological class First-Generation Cephalosporin Antibiotic
Common use (General) Treating bacterial infections
Origin Semisynthetic compound

1. Cefadroxil: Definition, Class, and General Purpose

Cefadroxil Sinphar is a trade name for the prescription-only medication whose active ingredient is Cefadroxil, a semisynthetic beta-Lactam antibiotic clinically recognized for its effectiveness against susceptible bacteria.

Cefadroxil is chemically categorized as a first-generation cephalosporin. The drug is known for its long-acting profile, often allowing for less frequent daily dosing compared to some short-acting first-generation cephalosporins. Its general purpose is defined by its class: to eliminate susceptible bacteria and facilitate the patient's recovery from a confirmed bacterial illness.


2. Composition, Forms, and Origin

Cefadroxil Sinphar is a single-ingredient product available for oral administration in multiple dosage forms, which typically include the oral capsule, oral tablet, and a powder for oral suspension.

Cefadroxil itself is a semisynthetic derivative of the cephalosporin structure, making it highly acid-stable and suitable for efficient absorption after oral ingestion. The availability of multiple forms ensures patient flexibility, as the solid forms are taken with excipients, while the suspension is prepared using an aqueous vehicle base, accommodating various patient groups, including children, who may require the liquid form.


3. The Bactericidal Principle

The medication’s function is based on a bactericidal principle, meaning its action is lethal to the infectious agent rather than just halting its growth.

Cefadroxil achieves this by targeting the integrity of the bacterial cell wall. It works by binding to specific proteins within the bacterial structure, which effectively causes the inhibition of cell wall synthesis, leading to the irreversible failure and subsequent elimination of susceptible bacteria. This process ensures the drug actively destroys the infectious bacteria rather than merely suppressing their growth, serving the ultimate general purpose of clearing the infection.

Regulatory References

  1. Cefadroxil: MedlinePlus Drug Information

What side effects are possible with Cefadroxil Sinphar?

Possible side effects and safety information

The safety profile for Cefadroxil, the active ingredient in Cefadroxil Sinphar, is established through comprehensive regulatory documentation, which categorizes adverse reactions by frequency and affected organ system.

Frequency-Classified Adverse Reactions

The adverse events documented in official prescribing information are classified into standard frequency tiers:

  • Common: Reactions affecting the gastrointestinal system, such as nausea, vomiting, diarrhea, abdominal pain, and dyspepsia. Skin reactions, including pruritus (itching) and rash, are also commonly noted.
  • Uncommon: Adverse events resulting from the overgrowth of opportunistic organisms, such as vaginal mycoses (thrush).
  • Rare: Includes specific blood disorders (e.g., leucopenia, agranulocytosis) often reported during prolonged use, as well as serum sickness-like reactions and interstitial nephritis.
  • Very Rare: Immediate allergic reactions, such as anaphylactic shock, are classified as very rare.
  • Not Known: The frequency of severe conditions like pseudomembranous colitis, Stevens-Johnson syndrome, and toxic epidermal necrolysis cannot be estimated from available data, but these are explicitly documented.

Safety Considerations and Restrictions

Official labeling defines specific safety limitations. The medication is contraindicated in individuals with a known hypersensitivity to any cephalosporin antibiotic. Caution is required in patients with markedly impaired renal function due to the risk of drug accumulation, and careful observation is required for these individuals throughout therapy. Similarly, patients with a documented history of penicillin allergy or gastrointestinal disease, particularly colitis, require specific caution as per regulatory documents. Low concentrations of Cefadroxil are reported to be excreted in breast milk.

Overdose and Emergency Response

Overdose and When to Seek Help

This information details the officially documented toxic reactions and necessary emergency actions for Cefadroxil, as described in government regulatory sources.

Documented Manifestations and Serious Outcomes

Regulatory documents outline that an overdose may lead to acute toxic reactions, often starting with gastrointestinal symptoms like nausea, vomiting, and diarrhea, and potentially leading to electrolytic disorders.

More serious manifestations documented include central nervous system effects such as reduced consciousness, muscular fasciculations, myoclonia, cramps, and coma. The risk of seizures is specifically increased in patients with impaired kidney function following high exposures.

Severe outcomes that have been associated with this class of medication include the possibility of anaphylactic shock and acute kidney insufficiency.

Required Emergency Actions

Immediate medical attention is required for a suspected overdose. Official guidance states to seek help immediately or call the Poison Help line.

Urgent medical services (e.g., 911) must be called if the affected person displays life-threatening symptoms, including collapse, seizure, trouble breathing, or inability to be awakened.

Official management procedures are symptomatic and supportive, which may include gastric emptying, activated charcoal, and potentially dialysis in severe cases or impaired kidney function. No specific antidote is listed in the regulatory documents.

Therapeutic Uses of Cefadroxil Sinphar

Cefadroxil Sinphar is a prescription medication used to address bacterial infections across several key domains. Its therapeutic application is focused on addressing the underlying bacterial cause of acute illness, and supports recovery from acute illness. Its application is commonly used to help with providing supportive relief from the disruptive symptoms associated with active bacterial invasion.

The medication is relevant for managing bacterial infections, which typically includes conditions such as cellulitis, abscesses, streptococcal pharyngitis (strep throat), bacterial tonsillitis, and uncomplicated lower urinary tract infections (UTIs).

“Cefadroxil is applied in contexts involving heightened symptoms of pain and inflammation, providing support that helps ease the overall symptom burden.”

The overall benefit is concentrated on easing symptoms related to physical discomfort and supporting functional stability during episodes of infection.

Quick Fact: Supportive Management of Localized Symptoms
Commonly used to help with acute inflammatory discomfort, such as redness, swelling, and localized pain in skin infections.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility and Contraindications

Official regulatory information defines specific populations for whom Cefadroxil use is either prohibited or requires strict caution.

Category Regulatory Status Constraint Details
Absolute Contraindication Must Not Use Patients with a known allergy to the cephalosporin class of antibiotics or a history of severe hypersensitivity reaction to penicillin or other beta-lactam drugs, due to documented cross-sensitivity.
Conditional Use (Caution) Use With Caution Individuals with markedly impaired renal function (creatinine clearance < 50 mL/ min), requiring dose adjustment to prevent accumulation. Patients with a history of gastrointestinal disease, particularly colitis.
Age-Related Established/Not Recommended Use is established for susceptible infections in children. The capsule/tablet form is not recommended for children under six years of age. Elderly patients are eligible but require careful renal function monitoring.
Pregnancy/Lactation Unestablished/Not Recommended The safety of use during pregnancy has not been established in adequate controlled studies; use is only if clearly needed. Cefadroxil is excreted into breast milk, and some regulators advise that nursing mothers should discontinue breastfeeding.

Eligibility to use Cefadroxil is conditional upon the absence of beta-lactam allergy and is restricted by the degree of kidney function impairment, which necessitates a mandatory dosing schedule adjustment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Cefadroxil defines interaction constraints across several domains, primarily related to renal clearance and pharmacodynamic risk augmentation. The following interactions are documented:

Documented Pharmacokinetic and Pharmacodynamic Interactions

Interacting Agent or Class Documented Interaction Pattern
Probenecid (OAT Inhibitor) Co-administration reduces the renal elimination of Cefadroxil, resulting in increased plasma concentrations (exposure).
Bacteriostatic Antibiotics Combination is not recommended due to potential antagonistic effects which may reduce antibacterial action.
Oral Anticoagulants (e.g., Warfarin) Associated with an increased risk or severity of bleeding when co-administered.
Live Bacterial Vaccines May reduce the immune response to the vaccine, potentially resulting in less effective vaccination.
Nephrotoxic Agents Co-administration may potentiate nephrotoxic effects (increase the risk of kidney toxicity).

Specific Interaction Constraints

The interaction profile also includes several constraints and patient-condition considerations. In patients with impaired renal function, reduced clearance can lead to drug accumulation and a heightened risk of central nervous system adverse reactions. The administration status is noted as not significantly affected by food, meaning the medicine can be taken with or without meals. Furthermore, Cefadroxil can lead to a transient positive Direct Coombs' test result and may cause false positive reactions in certain urinary sugar reduction tests.

Mechanism of Action

Targeting Penicillin-Binding Proteins

Cefadroxil works by targeting the specific enzymatic machinery that mediates the synthesis of the bacterial cell wall. As a beta-lactam structure, it acts primarily on the bacterial cell wall synthesis pathway. It engages enzymes crucial for the cross-linking of peptidoglycan components by binding to specific Penicillin-Binding Proteins (PBPs), which are transpeptidases located inside the bacterial cell wall. This domain of action focuses on irreversible inhibition of key transpeptidases (PBPs).


Inhibition of Peptidoglycan Cross-Linking

By binding covalently to PBPs, Cefadroxil blocks the final, crucial step of peptidoglycan synthesis—the transpeptidation reaction. Peptidoglycan is a complex polymer that provides the cell wall's structural integrity. This modification of molecular steps results in an impaired peptidoglycan layer lacking structural integrity, preventing the cell wall from being properly constructed.


Resulting Physiological Effect: Osmotic Instability

The disruption of the cell wall structure leads to a physiological consequence: the bacterial cell loses structural integrity and undergoes osmotic instability. This results in the uncontrolled influx of water, initiating the mechanistic cascade that compromises the cell's physical integrity.

Dosage and Administration Information

Official Administration Guidelines

Cefadroxil is a cephalosporin antibiotic administered by the oral route (by mouth) for the treatment of bacterial infections. It is available in various forms, including capsules, tablets, and a powder for oral suspension. The dosage and duration of therapy are determined by the treating physician based on the specific infection and the patient's renal function.

Dosing and Timing

Frequency: Cefadroxil is typically taken once daily (q.d.) or in two equally divided doses twice daily (b.i.d.). It should be taken at approximately the same time(s) each day to maintain consistent drug levels.

With or Without Food: The medication may be taken with or without food. Taking the dose with food can help diminish potential gastrointestinal discomfort sometimes associated with oral cephalosporin therapy.

Duration: It is critical to complete the full prescribed course of therapy, even if symptoms improve early. For infections involving beta-hemolytic streptococci, treatment must continue for at least 10 days to prevent complications. Treatment duration is often maintained for 2 to 3 days after acute clinical symptoms have disappeared.

Preparation and Special Conditions

Oral Suspension: If using the liquid form, the bottle must be shaken well before each use to ensure the dose is uniformly mixed. The dose should be measured using an appropriate measuring spoon, oral syringe, or cup provided, not a standard household spoon.

Missed Dose: If a dose is missed, take it as soon as it is remembered. However, if it is almost time for the next scheduled dose, skip the missed dose and continue the regular dosing schedule. Do not take a double dose to make up for a missed one.

Renal Impairment: The dosage must be adjusted for adults with markedly impaired renal function (creatinine clearance leq 50 mL/ min/1.73 m^2) to prevent accumulation of the drug. The initial dose is typically 1000 mg, followed by a 500 mg maintenance dose at extended intervals (e.g., every 12, 24, or 36 hours) depending on the degree of impairment.

Recent Clinical Evidence

Research evidence / Overview of studies for Cefadroxil Sinphar

Evidence for Use in Pharyngitis and Tonsillitis

Research has explored the use of Cefadroxil for conditions associated with acute or disruptive episodes, specifically pharyngitis and tonsillitis caused by susceptible bacteria. Studies often compared it to other established antibiotic therapies during research exploring short-term symptom changes. The main focus of these trials was studied for measuring bacteriological eradication and clinical success, which monitors the resolution of outcomes related to physical discomfort. Trials reported how symptoms evolved in the observed populations and measured post-treatment outcomes to assess recurrence rates. However, long-term effects are not fully established.

Evidence for Use in Skin and Skin Structure Infections

The research examined Cefadroxil for infections like cellulitis and impetigo, using active-controlled trials. Researchers monitored outcomes linked to inflammatory or irritative states, such as the resolution of redness and swelling, alongside confirming bacteriological eradication. Findings describe patterns observed in the studies over the defined treatment intervals. Some studies also explored whether taking the medication once daily was associated with different outcomes compared to a divided daily regimen. The evidence quality varies across studies, and data related to outcomes for patients with severe, deep-seated skin infections remain limited.

Summary of Research Gaps and Uncertainties

The evidence quality varies across studies, with some key findings relying on older study designs, which may not provide the same level of granularity as modern trials. Sample sizes were modest in some early comparative research, meaning subgroup findings are uncertain. Additionally, comparative evidence is lacking in some areas against the newest generations of antibiotics now used for similar conditions. Ultimately, the research highlights what is known — and what is still uncertain — about Cefadroxil.

Frequently Asked Questions (FAQ)

Common questions about Cefadroxil Sinphar (FAQ)


Q: What is the reason a person is advised to take the full prescribed course of Cefadroxil Sinphar?

Official information emphasizes the importance of completing the entire course of Cefadroxil Sinphar as prescribed, even if symptoms begin to improve quickly. This practice is intended to eliminate susceptible bacteria and is associated with preventing serious complications, such as subsequent rheumatic fever after a strep infection. This full course also helps limit the potential development of drug-resistant bacteria.


Q: Is Cefadroxil Sinphar generally suitable for use by older adults or the elderly?

Yes, official documents indicate that elderly patients are generally eligible to use Cefadroxil Sinphar. However, use in older adults is treated with caution due to the possibility of the medication accumulating, particularly if they have existing impaired renal function (kidney problems). Official guidelines note that careful kidney function monitoring is often required for this population.


Q: Is there a concern about taking Cefadroxil Sinphar if a person has a history of kidney problems?

Official regulatory information states that Cefadroxil Sinphar must be used with care if a person has a history of markedly impaired renal function (significant kidney problems). This is because the kidneys help clear the drug from the body, and the drug may accumulate if they are impaired. Therefore, official guidance describes that the dosage schedule is modified for these patients to reduce the risk of side effects, including central nervous system adverse reactions.


Q: What are the signs that a side effect might be serious and require medical attention?

Official information describes signs that may require medical evaluation. These include signs of a serious allergic reaction, such as trouble breathing, swelling of the face or throat, or a severe, widespread rash or hives. Additionally, signs of a serious infection in the gut—such as severe, watery diarrhea with stomach cramps, fever, and nausea—are described as requiring immediate medical evaluation.


Q: Are there any known interactions between Cefadroxil Sinphar and live bacterial vaccines, such as the typhoid vaccine?

Yes, official product information documents an interaction between Cefadroxil and live bacterial vaccines. Co-administration may reduce the immune response to the vaccine, which regulatory documents describe as potentially resulting in less effective vaccination.


Q: What is the difference between Cefadroxil Sinphar and other common antibiotics like Amoxicillin?

The primary difference lies in their chemical classification. Cefadroxil is classified as a first-generation cephalosporin antibiotic, while Amoxicillin belongs to the penicillin class. Official safety constraints note that individuals with a severe penicillin allergy may have a cross-sensitivity risk with cephalosporins like Cefadroxil.


Q: Is it true that Cefadroxil Sinphar can cause a serious condition called C. difficile-associated diarrhea?

Official documents indicate that antibiotics, including Cefadroxil, can sometimes disturb the natural bacteria in the gut, which allows an overgrowth of Clostridioides difficile bacteria. This overgrowth may lead to a serious condition known as pseudomembranous colitis, which is the most severe form of C. difficile-associated diarrhea. This specific reaction is documented in the safety information.


Q: Can Cefadroxil Sinphar be used to treat viral illnesses like the common cold or flu?

No, official regulatory documents state that Cefadroxil Sinphar is indicated only for infections that are proven or strongly suspected to be caused by susceptible bacteria. The drug's mechanism is not effective against viruses, which cause the common cold, flu, and similar illnesses.


Q: Is Cefadroxil Sinphar considered a broad-spectrum antibiotic?

Cefadroxil is categorized as a first-generation cephalosporin. While it targets a range of susceptible bacteria, some official documents note that it may be preferred over newer-generation cephalosporins in certain cases because those newer drugs often have broader spectrums of activity (meaning they target a wider variety of bacterial types).


Q: Can Cefadroxil Sinphar affect the effectiveness of oral contraceptive (birth control) medications?

Official information and related studies indicate that antibiotics like Cefadroxil may reduce the effectiveness of combined oral contraceptives in some women. This potential interaction is associated with an increased risk for pregnancy. Official information may describe the need for alternative contraceptive methods when Cefadroxil is used concurrently.


Q: Is it generally acceptable to consume alcohol while using Cefadroxil Sinphar?

Official drug monographs advise that patients should discuss the use of alcohol with their healthcare professional before or while taking Cefadroxil Sinphar. While a specific, absolute contraindication may not be provided in all regulatory documents, it is noted as a standard caution point for users.


Q: Can Cefadroxil Sinphar cause unusual tiredness or dizziness?

Official safety data lists adverse reactions involving the nervous system. Dizziness and headache are explicitly reported reactions. Additionally, feelings of unusual tiredness or weakness have been documented as potential side effects.


Q: Can Cefadroxil Sinphar cause jaundice or liver issues?

Yes, official regulatory safety data lists reports of hepatic dysfunction (liver issues) associated with Cefadroxil use. These reports have included conditions such as cholestasis (reduced bile flow) and elevations in liver enzyme levels, and in rare cases, idiosyncratic hepatic failure.


Q: What types of bacteria is Cefadroxil Sinphar usually prescribed to target?

Official documents specify that Cefadroxil Sinphar is prescribed for infections caused by certain susceptible strains of bacteria. These include organisms like Staphylococcus aureus, Streptococcus pyogenes (which causes strep throat), Escherichia coli, Klebsiella species, and Proteus mirabilis.


Q: Are there specific instructions for the disposal of unused or expired Cefadroxil Sinphar liquid suspension?

Regulatory guidance and official disposal recommendations state that unused or expired medication should be disposed of according to professional guidance or by taking them to an established drug take-back program. Medicines should not be disposed of by flushing them down a toilet or pouring them down a drain (wastewater) unless specifically instructed to do so.


Q: Are seizures a reported side effect of Cefadroxil Sinphar?

Yes, seizures are listed as a serious, though rare, adverse reaction in the official safety profile. This effect is sometimes reported, particularly in patients who have impaired renal function (kidney problems) and whose dosage was not appropriately reduced to prevent drug accumulation.

How should Cefadroxil Sinphar be stored and disposed of?

Storage and Disposal Requirements

The storage of Cefadroxil Sinphar must adhere strictly to regulatory conditions, varying by formulation.


Storage by Formulation

Cefadroxil Capsules and Tablets must be stored at Controlled Room Temperature (20 C to 25 C) in a closed container.

Cefadroxil Oral Suspension (reconstituted) must be stored in the refrigerator and must not be frozen. The container must be kept tightly closed.

Stability Constraint: The reconstituted suspension has an official shelf-life of 14 days and any unused portion must be discarded after this period.


General Requirements

All forms must be stored out of the reach of children. Unused or expired medication must be discarded according to professional guidance. Medicines should not be disposed of in wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cefadroxil Sinphar found in:

A-Z Index: